We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




FFPE RNA Purification Kit

By Biotechdaily staff writers
Posted on 19 May 2008
New formalin-fixed paraffin-embedded (FFPE) RNA purification kits will allow users to extract high quality RNA and DNA from FFPE archival samples for several downstream applications including quantitative polymerase chain reaction (qPCR), RT-PCR, microarray expression profiling, and mutation screening. More...


Norgen Biotek Corp. (Thorold, ON, Canada), a biotechnology company focusing primarily on advancing tools for RNA, DNA, and protein purifications, announced the expansion of its RNA product range by launching the FFPE RNA purification kit. Moreover, Norgen is also offering a kit that recovers both RNA/DNA from FFPE archival samples, the FFPE RNA/DNA purification kit.

A key feature of Norgen's FFPE extraction kits is that they isolate both small and large RNA sequences from the sample. Other commercially available kits use high concentrations of ethanol, which favor the extraction of small RNA sequences and result in poor yields of larger RNA, although the large RNA sequences in the FFPE samples may not be too badly degraded and could be used for some downstream applications. With Norgen's kit, no assumptions are made about the quality of large RNA that may be present in the sample, and therefore, both the small RNA and the large RNA sequences will be recovered.

"The FFPE purification kits are an excellent addition to our already successful line of RNA purification, concentration and clean-up kits,” said Dr. Haj-Ahmad, president and CEO of Norgen Biotek. "We offer competitive products of the highest quality for all areas of RNA research, including total RNA extraction, microRNA enrichment, and the 3-in-1 purification of RNA/DNA/proteins. This latest addition of FFPE RNA and DNA extraction kits solidifies our position as an innovative company in the RNA purification market segment.”

Norgen was recently recognized as one of Canada's Top 10 life-science companies. Norgen specializes in the research, development, manufacture, and marketing of a variety of commercial sample preparation products derived from its proprietary technology. Currently, this technology is used in protein, RNA and DNA purification, isolation, and concentration and clean-up kits. Norgen is actively working on the adoption of this enabling technology into the diagnostic market as well as industrial-scale applications.


Related Links:
Norgen Biotek

New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The discovery of early markers for ovarian cancer that would have improved sensitivity could aid detection (Photo courtesy of Adobe Stock)

Highly Accurate Biomarkers Could Detect Ovarian Cancer Before Clinical Diagnosis

Ovarian cancer is a deadly and challenging disease, primarily because early detection is difficult. Most women (70-75%) are diagnosed only after the cancer has already spread, which significantly reduces... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.